Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice: A Nationwide Cohort Study From Sweden

IMPORTANCE: Considering the widespread and increasing use of biological immunomodulators (biological disease-modifying antirheumatic drugs [bDMARDs]) to treat chronic inflammatory conditions, and the concern that immunomodulation may alter cancer risk and progression, the limited available data on u...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :JAMA Intern Med
Главные авторы: Wadström, Hjalmar, Frisell, Thomas, Askling, Johan
Формат: Artigo
Язык:Inglês
Опубликовано: American Medical Association 2017
Предметы:
Original Investigation
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5710271/
https://ncbi.nlm.nih.gov/pubmed/28975211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamainternmed.2017.4332
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы